Floatz logo

Tolcapone

Brain Injuries, Traumatic

Sheppard Pratt Health SystemSmall moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

93 Active assets in the Brain Injuries, Traumatic cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
PROPRANOLOL
Tanta University
Phase 4BBB
N-Acetyl-L-Cysteine
HonorHealth Research Institute
Phase 2BB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB

View all 50 →

Same molecule, other indications

Tolcapone is also rated in:

Parkinson diseaseDormant
B
Indicative ·
58 / 100
View asset →
frontotemporal dementiaDormant
B
Indicative ·
57 / 100
View asset →
Neurocognitive DisordersDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →